The inhalation toxicology of ricin (supplied by Sigma) from the seed v
ariety ''Hale Queen'' and abrin was examined following head-only expos
ure of rats to a range of concentrations of each toxin generated as an
aerosol from solution using a constant-output nebulizer. The inhalati
on toxicity of an in-house preparation of ricin from a different seed
type, Ricinus communis var. zanzibariensis (R. zanzibariensis), was al
so assessed for comparison. The approximate LCt50 values determined we
re very similar for the Sigma ricin and abrin (4.54-5.96 and 4.54 mg m
in m(-3), respectively). However, the LCt50 of ricin toxin prepared in
-house from seeds of the R. zanzibariensis variety was assessed to be
12.7 mg min m(-3). Ricin prepared from this seed variety was therefore
less toxic than Sigma ricin by a factor of almost threefold. Given th
at both ricin preparations were pure by silver-stained, sodium dodecyl
sulfate polyacrylamide electrophoresis gels, the data must reflect di
fferences in specific toxicity between seed varieties. The histopathol
ogy was studied in a separate group of experimental animals exposed to
approximate LCt30 levels of each in-house toxin preparation and was f
ound to be entirely restricted to the lung. The overall pattern and ti
me course of damage observed were similar for ricin and abrin and were
characterized by rapidly progressive and overwhelming pulmonary edema
accompanied by acute destructive alveolitis and necrosis/apoptosis of
the lower respiratory tract epithelium; severe intraalveolar edema an
d resulting hypoxia accounted for the majority of deaths in the decede
nt population. The resolution phase of the pulmonary damage in those a
nimals destined to survive was heralded by a gradual disappearance of
edema fluid accompanied by generalized, focally florid, hyperplasia of
type II pneumocytes and striking transitory consolidation of the lung
parenchyma by chronic inflammatory cells. Despite many similarities i
n histopathology between abrin and ricin there were some differences.
Although by systemic administration abrin is several times more toxic
than ricin, when delivered by inhalation there was no significant diff
erence in potency between abrin and the commercial preparation of rici
n (Sigma).